| Literature DB >> 31715282 |
B Hasse1, M M Hannan2, P M Keller3, F P Maurer4, R Sommerstein5, D Mertz6, D Wagner7, N Fernández-Hidalgo8, J Nomura9, V Manfrin10, D Bettex11, A Hernandez Conte12, E Durante-Mangoni13, T H-C Tang14, R L Stuart15, J Lundgren16, S Gordon17, M C Jarashow18, P W Schreiber19, S Niemann20, T A Kohl20, C L Daley21, A J Stewardson22, C J Whitener23, K Perkins24, D Plachouras25, T Lamagni26, M Chand27, T Freiberger28, S Zweifel29, P Sander30, B Schulthess31, J E Scriven32, H Sax19, J van Ingen33, C A Mestres34, D Diekema35, B A Brown-Elliott36, R J Wallace36, L M Baddour37, J M Miro50, B Hoen47, E Athan40, A Bayer41, B Barsic42, G R Corey43, V H Chu44, D T Durack44, C Q Fortes45, V Fowler46, B Hoen47, A W Krachmer48, E Durante-Magnoni49, J M Miro50, W R Wilson51.
Abstract
Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating in these patients. In this document the International Society for Cardiovascular Infectious Diseases (ISCVID) covers aspects of prevention (field of hospital epidemiology), clinical management (infectious disease specialists, cardiac surgeons, ophthalmologists, others), laboratory diagnostics (microbiologists, molecular diagnostics), device management (perfusionists, cardiac surgeons) and public health aspects.Entities:
Keywords: Cardiopulmonary bypass; Disseminated; Guidelines; Heater-cooler device; ISCVID; Infection; Mycobacterial; Mycobacterium chimaera; Outbreaks
Mesh：
Substances：
Year: 2019 PMID： 31715282 DOI： 10.1016/j.jhin.2019.10.009
Source DB: PubMed Journal: J Hosp Infect ISSN： 0195-6701 Impact factor: 3.926